---
layout: post
title: "Non-Clinical Performance Assessment of Tissue Containment Systems Used During Power Morcellation Procedures; Draft Guidance for Industry and Food and Drug Administration Staff; Availability"
date: 2026-02-05 18:59:34 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2022-13212
original_published: 2022-06-21 00:00:00 +0000
significance: 8.00
---

# Non-Clinical Performance Assessment of Tissue Containment Systems Used During Power Morcellation Procedures; Draft Guidance for Industry and Food and Drug Administration Staff; Availability

**Published:** February 05, 2026 18:59 UTC
**Source:** Federal Register
**Original Published:** June 21, 2022 00:00 UTC
**Document Number:** 2022-13212

## Summary

The Food and Drug Administration (FDA or Agency) is announcing the availability of the draft guidance entitled "Non-Clinical Performance Assessment of Tissue Containment Systems Used During Power Morcellation Procedures." This draft guidance document provides recommendations that may help manufacturers comply with the special controls related to non-clinical performance data for gynecologic and general laparoscopic power morcellation containment systems. This draft guidance is not final nor is it for implementation at this time.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2022/06/21/2022-13212/non-clinical-performance-assessment-of-tissue-containment-systems-used-during-power-morcellation)
- API: https://www.federalregister.gov/api/v1/documents/2022-13212

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
